Abbott launches SimpleScreen CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
First Canadian Commercial Use of Abbott's Volt Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care
Abbott receives FDA approval for its TactiFlex Duo Ablation Catheter to treat people with abnormal heart rhythms
Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula
Abbott's next-generation Amulet 360 device receives CE Mark to treat people with atrial fibrillation at risk of stroke
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents
Market One Minute Feature on BNN Bloomberg: Omega Pacific Resources Drills to Expand Gold Discovery in BC's Toodoggone
QIMC Engages Global Seismic Processing Leader Earth Signal to Advance Nova Scotia Hydrogen and Helium Multi-Gas Pilot Production Pathway
